Ali Mohamed

Ali Mohamed

Company: Immatics

Job title: Vice President of CMC

Seminars:

Workshop G: Manufacturing Innovations to Improve Robustness of T-Cell Therapies 9:00 am

Measures to increase success rates and manufacturing yields of genetically modified T-cells Reviewing current and future strategies to manufacture autologous products, reduce variability, increase success rates and reduce cost and turn-around timesRead more

day: Workshop - Track C - Morning

Developing Next-Generation TCR-T Therapies by CD8 Co-Expression 11:45 am

Outlining next-gen approaches for TCR-engineered T-cell therapies for solid tumors Enhancement of anti-tumor immune responses through effective engagement of CD4 T cells Exploring the differential functional profiles of TCR-T cells co-expressing different types of CD8 co-receptors          Read more

day: Day 2 - Track C - Morning

Roundtable Discussion- Manufacturing Innovations to Improve Robustness of T cell Therapies 6:00 pm

Measures to increase success rates and manufacturing yields of genetically modified T cells Reviewing current and future strategies to manufacture autologous products, reduce variability, increase success rates and reduce cost and turn-around timesRead more

day: Day 1 – Track C – Evening

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.